| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 37.746 | 52.491 | 45.660 | 35.552 | 19.779 | 16.446 | 21.104 | 17.694 | 11.952 | 13.518 |
| Total Income - EUR | 38.319 | 52.605 | 45.832 | 35.758 | 19.779 | 16.446 | 21.104 | 17.694 | 11.952 | 13.518 |
| Total Expenses - EUR | 29.879 | 31.607 | 32.412 | 31.787 | 22.738 | 19.868 | 18.078 | 16.085 | 17.017 | 19.700 |
| Gross Profit/Loss - EUR | 8.440 | 20.998 | 13.420 | 3.971 | -2.959 | -3.422 | 3.027 | 1.609 | -5.064 | -6.182 |
| Net Profit/Loss - EUR | 5.556 | 20.134 | 10.390 | 3.614 | -3.160 | -3.577 | 2.814 | 1.426 | -5.185 | -6.588 |
| Employees | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Dobimed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 22.130 | 70.358 | 55.099 | 40.102 | 32.404 | 24.205 | 16.588 | 9.698 | 3.170 | 0 |
| Current Assets | 30.330 | 28.671 | 35.647 | 12.148 | 7.793 | 6.312 | 14.007 | 4.781 | 2.414 | 1.057 |
| Inventories | 0 | 1.693 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 12.942 | 13.227 | 10.996 | 10.242 | 6.499 | 2.286 | 0 | 0 | 0 | 0 |
| Cash | 17.387 | 13.751 | 24.651 | 1.906 | 1.294 | 4.026 | 14.007 | 4.781 | 2.414 | 1.057 |
| Shareholders Funds | 25.865 | 20.351 | 11.786 | 4.439 | 1.193 | -2.407 | 460 | 1.887 | -3.304 | -9.874 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 26.595 | 78.859 | 79.064 | 48.099 | 39.177 | 33.116 | 30.250 | 14.688 | 11.442 | 13.550 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Dobimed Srl